Jose Carmona
2021 - Rubius Therapeutics
In 2021, Jose Carmona earned a total compensation of $659.2K as Chief Financial Officer at Rubius Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $200,250 |
|---|---|
| Salary | $450,000 |
| Other | $8,945 |
| Total | $659,195 |
Carmona received $450K in salary, accounting for 68% of the total pay in 2021.
Carmona also received $200.3K in non-equity incentive plan and $8.9K in other compensation.
Rankings
In 2021, Jose Carmona's compensation ranked 10,078th out of 12,415 executives tracked by ExecPay. In other words, Carmona earned more than 18.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,078 out of 12,415 | 19th |
Division Manufacturing | 4,464 out of 5,505 | 19th |
Major group Chemicals And Allied Products | 1,989 out of 2,375 | 16th |
Industry group Drugs | 1,767 out of 2,096 | 16th |
Industry Biological Products, Except Diagnostic Substances | 383 out of 449 | 15th |
Source: SEC filing on March 30, 2022.
Carmona's colleagues
We found four more compensation records of executives who worked with Jose Carmona at Rubius Therapeutics in 2021.
News
Rubius Therapeutics CEO Pablo Cagnoni's 2021 pay jumps 45% to $5M
March 30, 2022
Radius Health CEO G Martin's 2020 pay jumps 2,116% to $12M
April 22, 2021
Radius Health CEO Jesper Hoeiland's 2019 pay falls 28% to $3.9M
April 17, 2020
Radius Health CEO Jesper Høiland's 2018 pay falls 29% to $5.4M
April 18, 2019